Ignite Creation Date:
2024-05-05 @ 7:02 PM
Last Modification Date:
2024-10-26 @ 9:41 AM
Study NCT ID:
NCT00591851
Status:
COMPLETED
Last Update Posted:
2023-09-25
First Post:
2007-12-26
Brief Title:
Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide AC Followed By Paclitaxel With Trastuzumab in HER2 NEU-Amplified Breast Cancer Feasibility
Sponsor:
Organization:
Memorial Sloan Kettering Cancer Center